Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H LUND

Showing results (501-510 of 826) with videos related to

Pageof 83
Sort By:
International Journal of Cardiology|July 10, 2016
Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF)Abel Makubi, Camilla Hage, Ulrik Sartipy, et al.
Scandinavian Cardiovascular Journal : SCJ|February 20, 2019
Continuous-flow LVADs in the Nordic countries: complications and mortality and its predictorsOscar Ö Braun, Johan Nilsson, Finn Gustafsson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 10, 2006
Excessive weight gain in cardiac transplant recipientsJill J Williams, Lars H Lund, John LaManca, et al.
Scandinavian Journal of Gastroenterology|April 15, 2020
Increase in the incidence of alcoholic pancreatitis and alcoholic liver disease in Iceland: impact of <i>per capita</i> alcohol consumptionKristjan Hauksson, Margret Arnardottir, Arnar S Agustsson, et al.
The American Journal of Cardiology|April 7, 2018
Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection FractionCamilla Hage, Mette Bjerre, Jan Frystyk, et al.
Oncogene|February 8, 2012
Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivoE Leucci, A Zriwil, L H Gregersen, et al.
Journal of Cardiac Failure|May 13, 2022
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure PopulationTonje Thorvaldsen, Giulia Ferrannini, Linda Mellbin, et al.
ESC Heart Failure|August 10, 2021
Predictors of long-term outcome in heart failure with preserved ejection fraction: a follow-up from the KaRen studyAngiza Shahim, Marion Hourqueig, Erwan Donal, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 19, 2023
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey IIPaolo Gatti, Cecilia Linde, Lina Benson, et al.
RNA (New York, N.Y.)|December 18, 2013
Identification of expressed and conserved human noncoding RNAsMorten Muhlig Nielsen, Disa Tehler, Søren Vang, et al.
Pageof 83

Showing results (501-510 of 826) with videos related to

Sort By:
Pageof 83
International Journal of Cardiology|July 10, 2016
Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF)Abel Makubi, Camilla Hage, Ulrik Sartipy, et al.
Scandinavian Cardiovascular Journal : SCJ|February 20, 2019
Continuous-flow LVADs in the Nordic countries: complications and mortality and its predictorsOscar Ö Braun, Johan Nilsson, Finn Gustafsson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 10, 2006
Excessive weight gain in cardiac transplant recipientsJill J Williams, Lars H Lund, John LaManca, et al.
Scandinavian Journal of Gastroenterology|April 15, 2020
Increase in the incidence of alcoholic pancreatitis and alcoholic liver disease in Iceland: impact of <i>per capita</i> alcohol consumptionKristjan Hauksson, Margret Arnardottir, Arnar S Agustsson, et al.
The American Journal of Cardiology|April 7, 2018
Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection FractionCamilla Hage, Mette Bjerre, Jan Frystyk, et al.
Oncogene|February 8, 2012
Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivoE Leucci, A Zriwil, L H Gregersen, et al.
Journal of Cardiac Failure|May 13, 2022
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure PopulationTonje Thorvaldsen, Giulia Ferrannini, Linda Mellbin, et al.
ESC Heart Failure|August 10, 2021
Predictors of long-term outcome in heart failure with preserved ejection fraction: a follow-up from the KaRen studyAngiza Shahim, Marion Hourqueig, Erwan Donal, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 19, 2023
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey IIPaolo Gatti, Cecilia Linde, Lina Benson, et al.
RNA (New York, N.Y.)|December 18, 2013
Identification of expressed and conserved human noncoding RNAsMorten Muhlig Nielsen, Disa Tehler, Søren Vang, et al.
Pageof 83